Related Experiment Video
Updated: Mar 18, 2026
04:59
Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
13.2K
[New treatment options for chronic pruritus]
C Zeidler1, B Pfleiderer2, S Ständer3
1Kompetenzzentrum Chronischer Pruritus (KCP) und Klinik für Hautkrankheiten, Universitätsklinikum Münster, Von-Esmarch-Str. 58, 48149, Münster, Deutschland. claudia.zeidler@ukmuenster.de.
Summary
Chronic pruritus affects 14-17% of people, causing significant distress. Current therapies are limited, necessitating new treatments for this widespread condition.
Area of Science:
- Dermatology
- Internal Medicine
- Clinical Therapeutics
Background:
- Chronic pruritus is a prevalent and highly stressful symptom affecting 14-17% of the population.
- Despite advances in understanding its origins, effective and rapid therapeutic options remain limited.
- Patients experience prolonged suffering, leading to secondary somatic and psychosomatic disorders.
Purpose of the Study:
- To summarize current therapeutic strategies for chronic pruritus.
- To highlight the need for improved treatment options and clinical guidelines.
- To discuss emerging therapies under investigation in clinical trials.
Main Methods:
- Review of case series and individual randomized controlled trials.
- Analysis of the current S2K guideline for pruritus management.
- Synthesis of existing therapeutic approaches and emerging treatments.
Main Results:
- Current therapeutic options for chronic pruritus are insufficient for rapid and efficient symptom reduction.
- Interdisciplinary collaboration is crucial due to diverse etiologies and comorbidities.
- There is a significant need for standardized clinical studies, recommendations, and guidelines.
Conclusions:
- New therapeutic approaches are under investigation, offering future prospects for targeted therapies.
- Effective management of chronic pruritus requires a comprehensive, interdisciplinary approach.
- Further research and standardized guidelines are essential to improve patient outcomes.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
462
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
462
01:23Hand hygiene
6.4K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
6.4K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
849
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
849
01:29Inflammatory Bowel Disease IV: Pharmacological Management
902
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
902
01:15Anthelminthic Agents
11
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
11
01:26Psychosis: Goals of Pharmacotherapy
653
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
653